High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Tibolone (Livial) has been shown in previous studies to lower HDL cholesterol by up to 40%.
This study aims to study the effects of fenofibrate on HDL and subfractions in women taking
tibolone.